Aspivix Company

ASPIVIX is developing a new generation of medical devices that make gynecological procedures gentler and safer for women and gynecologists. The first device, CAREVIX, is designed to prevent cervix bleeding using a suction technology to replace traumatic tenaculum (forceps).
Technology: Longevity FemTech
Industry: FemTech
Headquarters: Vaud
Founded Date: 2015-01-01
Employees Number: 1-10
Funding Status: Early Stage Venture
Investors Number: 6
Total Funding: $7 568 022
Estimated Revenue: $1M to $10M
Last Funding Date: 2019-06-01
Last Funding Type: Grant

Visit Website
contact@aspivix.com
https://twitter.com/Aspivix_Health
Register and Claim Ownership